Document Detail


The hitchhikers guide to cancer stem cell theory: Markers, pathways and therapy.
MedLine Citation:
PMID:  22997049     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Cancer stem cell (CSC) biology is a rapidly developing field within cancer research. CSCs are postulated to be a unique cell population exclusively capable of infinite self renewal, multilineage differentiation and with ability to evade conventional cytotoxic cancer therapy. These traits distinguish CSCs from their more differentiated counterparts, which possess only limited or no potential for self renewal and tumor initiation. Therefore, CSCs would be the driving motor of malignant growth and therapy resistance. Accordingly, successful cancer treatment would need to eliminate this highly potent group of cells, since even small residual numbers would suffice to recapitulate the disease after therapy. Putative CSCs has been identified in a broad range of human malignancies and several cell surface markers have been associated with their stem cell phenotype. Despite all efforts, a pure CSC population has not been isolated and often in vitro clonogenic and in vivo tumorigenic potential is found in several cell populations with occasionally contradictory surface marker signatures. Here, we give a brief overview of recent advances in CSC theory, including the signaling pathways in CSCs that also appear crucial for stem cells homeostasis in normal tissues. We discuss evidence for the interaction of CSCs with the stromal tumor environment. Finally, we review the emerging potentially effective CSC-targeted treatment strategies and their future role in therapy. © 2012 International Society for Advancement of Cytometry.
Authors:
Akos Fábián; György Vereb; János Szöllősi
Related Documents :
19418469 - Cell survival and apoptosis-related molecules in cancer cells in effusions: a comprehen...
19140239 - Impact of p27mt gene on transplantation model of human colorectal cancer in nude mice.
23206989 - Placenta-specific novel splice variants of rho gdp dissociation inhibitor β are highly...
24970169 - Sphingosine 1-phosphate and cancer: lessons from thyroid cancer cells.
23358109 - Expression of osteoprotegerin from a replicating adenovirus inhibits the progression of...
23135359 - Endocrine gland-derived vascular endothelial growth factor strengthens cell invasion ab...
16002839 - Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract.
16204019 - A functional role for hemostasis in early cancer development.
17717129 - Genomic profiling of circulating plasma rna for the analysis of cancer.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-20
Journal Detail:
Title:  Cytometry. Part A : the journal of the International Society for Analytical Cytology     Volume:  -     ISSN:  1552-4930     ISO Abbreviation:  Cytometry A     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101235694     Medline TA:  Cytometry A     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 International Society for Advancement of Cytometry.
Affiliation:
Department of Biophysics and Cell Biology, Medical and Health Science Center, University of Debrecen, Hungary.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Students Aggress Against Professors in Reaction to Receiving Poor Grades: An Effect Moderated by Stu...
Next Document:  An approach for calculating a confidence interval from a single aquatic sample for monitoring hydrop...